{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:17:38Z","timestamp":1772165858901,"version":"3.50.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T00:00:00Z","timestamp":1692403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T00:00:00Z","timestamp":1692403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"UCR Opportunities to Advance Sustainability Innovation and Social Inclusion (OASIS) Internal Award"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54 MD013368"],"award-info":[{"award-number":["U54 MD013368"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54 MD013368"],"award-info":[{"award-number":["U54 MD013368"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54 MD013368"],"award-info":[{"award-number":["U54 MD013368"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54 MD013368"],"award-info":[{"award-number":["U54 MD013368"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54 MD013368"],"award-info":[{"award-number":["U54 MD013368"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institutes of Health SIG grant","award":["S10 OD026929"],"award-info":[{"award-number":["S10 OD026929"]}]},{"name":"National Institutes of Health SIG grant","award":["S10 OD026929"],"award-info":[{"award-number":["S10 OD026929"]}]},{"name":"UCR startup"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Health disparities in underserved communities, such as inadequate healthcare access, impact COVID-19 disease outcomes. These disparities are evident in Hispanic populations nationwide, with disproportionately high infection and mortality rates. Furthermore, infected individuals can develop long COVID with sustained impacts on quality of life. The goal of this study was to identify immune and endothelial factors that are associated with COVID-19 outcomes in Riverside County, a high-risk and predominantly Hispanic community, and investigate the long-term impacts of COVID-19 infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      112 participants in Riverside County, California, were recruited according to the following criteria: healthy control (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200923), outpatients with moderate infection (outpatient,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200933), ICU patients with severe infection (hospitalized,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200933), and individuals recovered from moderate infection (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200923). Differences in outcomes between Hispanic and non-Hispanic individuals and presence\/absence of co-morbidities were evaluated. Circulating immune and vascular biomarkers were measured by ELISA, multiplex analyte assays, and flow cytometry. Follow-up assessments for long COVID, lung health, and immune and vascular changes were conducted after recovery (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200923) including paired analyses of the same participants.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Compared to uninfected controls, the severe infection group had a higher proportion of Hispanic individuals (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200923,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.012) than moderate infection (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20098,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.550). Disease severity was associated with changes in innate monocytes and neutrophils, lymphopenia, disrupted cytokine production (increased IL-8 and IP-10\/CXCL10 but reduced IFN\u03bb2\/3 and IFN\u03b3), and increased endothelial injury (myoglobin, VCAM-1). In the severe infection group, a machine learning model identified LCN2\/NGAL, IL-6, and monocyte activation as parameters associated with fatality while anti-coagulant therapy was associated with survival. Recovery from moderate COVID infection resulted in long-term immune changes including increased monocytes\/lymphocytes and decreased neutrophils and endothelial markers. This group had a lower proportion of co-morbidities (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20098,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20091.0) but still reported symptoms associated with long COVID despite recovered pulmonary function.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study indicates increased severity of COVID-19 infection in Hispanic individuals of Riverside County, California. Infection resulted in immunological and vascular changes and long COVID symptoms that were sustained for up to 11\u00a0months, however, lung volume and airflow resistance was recovered. Given the immune and behavioral impacts of long COVID, the potential for increased susceptibility to infections and decreased quality of life in high-risk populations warrants further investigation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12889-023-16462-5","type":"journal-article","created":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T01:01:30Z","timestamp":1692406890000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Health disparities in COVID-19: immune and vascular changes are linked to disease severity and persist in a high-risk population in Riverside County, California"],"prefix":"10.1186","volume":"23","author":[{"given":"Kristina V.","family":"Bergersen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathy","family":"Pham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael T.","family":"Ulrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Merrill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxin","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumaya","family":"Alaama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinru","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Indira S.","family":"Harahap-Carrillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keita","family":"Ichii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shyleen","family":"Frost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus","family":"Kaul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Godzik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica C.","family":"Heinrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meera G.","family":"Nair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,19]]},"reference":[{"key":"16462_CR1","unstructured":"WHO Coronavirus (COVID-19) dashboard. https:\/\/covid19.who.int\/. Accessed 13 Feb 2023."},{"key":"16462_CR2","unstructured":"COVID data tracker. https:\/\/covid.cdc.gov\/covid-data-tracker\/#demographics. Accessed 13 Feb 2023."},{"key":"16462_CR3","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1007\/s11606-020-05916-w","volume":"35","author":"SAM Khatana","year":"2020","unstructured":"Khatana SAM, Groeneveld PW. Health disparities and the Coronavirus Disease 2019 (COVID-19) pandemic in the USA. J Gen Intern Med. 2020;35:2431\u20132.","journal-title":"J Gen Intern Med"},{"issue":"6","key":"16462_CR4","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1089\/pop.2022.0144","volume":"25","author":"M Zhao","year":"2022","unstructured":"Zhao M, Hamadi HY, Haley DR, Xu J, Tafili A, Spaulding AC. COVID-19 deaths and the impact of health disparities, hospital characteristics, community, social distancing, and health system competition. Popul Health Manag. 2022;25(6):807\u201313.","journal-title":"Popul Health Manag"},{"issue":"1","key":"16462_CR5","doi-asserted-by":"crossref","first-page":"ofad011","DOI":"10.1093\/ofid\/ofad011","volume":"10","author":"NM Gatto","year":"2023","unstructured":"Gatto NM, Freund D, Ogata P, Diaz L, Ibarrola A, Desai M, Aspelund T, Gluckstein D. Correlates of coronavirus disease 2019 inpatient mortality at a southern california community hospital with a predominantly Hispanic\/Latino adult population. Open Forum Infect Dis. 2023;10(1):ofad011.","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"16462_CR6","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1177\/08850666221149956","volume":"38","author":"A Rao","year":"2023","unstructured":"Rao A, Alnababteh MH, Avila-Quintero VJ, Flores JM, Laing NE, Boyd DA, et al. Association between patient race and ethnicity and outcomes with COVID-19: a retrospective analysis from a large mid-atlantic health system. J Intensive Care Med. 2023;38(5):472\u20138.","journal-title":"J Intensive Care Med"},{"key":"16462_CR7","unstructured":"Riverside County COVID-19 data and reports. https:\/\/coronavirus-countyofriverside.hub.arcgis.com\/. Accessed 13 Feb 2023."},{"key":"16462_CR8","doi-asserted-by":"publisher","unstructured":"Hazeldine J, Lord JM. Neutrophils and COVID-19: active participants and rational therapeutic targets.\u00a0Front Immunol. 2021;12. https:\/\/doi.org\/10.3389\/fimmu.2021.680134.","DOI":"10.3389\/fimmu.2021.680134"},{"key":"16462_CR9","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-2479844\/v1","author":"VLM Herrera","year":"2023","unstructured":"Herrera VLM, Bosch NA, Lok JJ, Nguyen MQ, Lenae KA, deKay JT, et al. Circulating neutrophil extracellular trap (NET)-forming \u201crogue\u201d neutrophil subset, immunotype [DEspR+CD11b+], mediate multi-organ failure in COVID-19 - an observational study. Res Sq. 2023. https:\/\/doi.org\/10.21203\/rs.3.rs-2479844\/v1.","journal-title":"Res Sq"},{"issue":"3","key":"16462_CR10","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.3390\/ijms24033001","volume":"24","author":"R Root-Bernstein","year":"2023","unstructured":"Root-Bernstein R. From co-infections to autoimmune disease via hyperactivated innate immunity: COVID-19 autoimmune coagulopathies, autoimmune myocarditis and multisystem inflammatory syndrome in children. Int J Mol Sci. 2023;24(3):3001.","journal-title":"Int J Mol Sci"},{"key":"16462_CR11","doi-asserted-by":"publisher","unstructured":"Rice CM, Lewis P, Ponce-Garcia FM, Gibbs W, Groves S, Cela D, et al. Hyperactive immature state and differential CXCR2 expression of neutrophils in severe COVID-19. Life Sci Alliance. 2023;6(2). https:\/\/doi.org\/10.26508\/lsa.202201658.","DOI":"10.26508\/lsa.202201658"},{"key":"16462_CR12","doi-asserted-by":"publisher","unstructured":"Leal VNC, Andrade MMS, Teixeira FME, Cambui RAG, Roa M, Marra LG, et al. Severe COVID-19 patients show a dysregulation of the NLRP3 inflammasome in circulating neutrophils. Scand J Immunol. 2022;97(3). https:\/\/doi.org\/10.1111\/sji.13247.","DOI":"10.1111\/sji.13247"},{"issue":"1","key":"16462_CR13","doi-asserted-by":"crossref","first-page":"9915","DOI":"10.1038\/s41598-022-13986-5","volume":"12","author":"S Ekstedt","year":"2022","unstructured":"Ekstedt S, Piersiala K, Petro M, Karlsson A, K\u00e5gedal \u00c5, Kumlien Geor\u00e9n S, Cardell LO. A prolonged innate systemic immune response in COVID-19. Sci Rep. 2022;12(1):9915.","journal-title":"Sci Rep"},{"key":"16462_CR14","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.119010","volume":"269","author":"S Meidaninikjeh","year":"2021","unstructured":"Meidaninikjeh S, Sabouni N, Marzouni HZ, Bengar S, Khalili A, Jafari R. Monocytes and macrophages in COVID-19: Friends and foes. Life Sci. 2021;269: 119010.","journal-title":"Life Sci"},{"issue":"6","key":"16462_CR15","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.7150\/thno.66831","volume":"12","author":"S Satta","year":"2022","unstructured":"Satta S, Meng Z, Hernandez R, Cavallero S, Zhou T, Hsiai TK, Zhou C. An engineered nano-liposome-human ACE2 decoy neutralizes SARS-CoV-2 Spike protein-induced inflammation in both murine and human macrophages. Theranostics. 2022;12(6):2639\u201357.","journal-title":"Theranostics"},{"issue":"6","key":"16462_CR16","doi-asserted-by":"crossref","first-page":"e245","DOI":"10.1016\/S2666-5247(20)30115-4","volume":"1","author":"B Hanley","year":"2020","unstructured":"Hanley B, Naresh KN, Roufosse C, Nicholson AG, Weir J, Cooke GS, Thursz M, Manousou P, Corbett R, Goldin R, et al. Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study. Lancet Microbe. 2020;1(6):e245\u201353.","journal-title":"Lancet Microbe"},{"issue":"1","key":"16462_CR17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3390\/v15010051","volume":"15","author":"AG Pappas","year":"2022","unstructured":"Pappas AG, Chaliasou AL, Panagopoulos A, Dede K, Daskalopoulou S, Moniem E, et al. Kinetics of immune subsets in COVID-19 patients treated with corticosteroids. Viruses. 2022;15(1):51.","journal-title":"Viruses"},{"key":"16462_CR18","doi-asserted-by":"publisher","unstructured":"Westmeier J, Paniskaki K, Karak\u00f6se Z, Werner T, Sutter K, Dolff S, et al. Impaired cytotoxic CD8(+) T cell response in elderly COVID-19 patients. mBio. 2020;11(5). https:\/\/doi.org\/10.1128\/mBio.02243-20.","DOI":"10.1128\/mBio.02243-20"},{"key":"16462_CR19","doi-asserted-by":"crossref","first-page":"107524","DOI":"10.1016\/j.carpath.2023.107524","volume":"64","author":"L Wu","year":"2023","unstructured":"Wu L, Jiang Z, Meulendijks ER, Baylan U, Waas ISE, Bugiani M, Tuinman PR, Fronczek J, Heunks LMA, de Groot JR, et al. Atrial inflammation and microvascular thrombogenicity are increased in deceased COVID-19 patients. Cardiovasc Pathol. 2023;64:107524.","journal-title":"Cardiovasc Pathol"},{"issue":"65","key":"16462_CR20","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1126\/sciimmunol.abk1741","volume":"6","author":"IS Cheon","year":"2021","unstructured":"Cheon IS, Li C, Son YM, Goplen NP, Wu Y, Cassmann T, Wang Z, Wei X, Tang J, Li Y, et al. Immune signatures underlying post-acute COVID-19 lung sequelae. Sci Immunol. 2021;6(65):1741.","journal-title":"Sci Immunol"},{"issue":"3","key":"16462_CR21","first-page":"401","volume":"24","author":"B Getachew","year":"2022","unstructured":"Getachew B, Landis HE, Manaye KF, Tizabi Y. COVID-19-associated coagulopathy: role of vitamins D and K. Curr Pharm Biotechnol. 2022;24(3):401\u201310.","journal-title":"Curr Pharm Biotechnol"},{"issue":"5","key":"16462_CR22","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/s41591-022-01810-6","volume":"28","author":"J Choutka","year":"2022","unstructured":"Choutka J, Jansari V, Hornig M, Iwasaki A. Unexplained post-acute infection syndromes. Nat Med. 2022;28(5):911\u201323.","journal-title":"Nat Med"},{"issue":"3","key":"16462_CR23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","volume":"21","author":"HE Davis","year":"2023","unstructured":"Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133\u201346.","journal-title":"Nat Rev Microbiol"},{"key":"16462_CR24","doi-asserted-by":"publisher","unstructured":"Wiech M, Chroscicki P, Swatler J, Stepnik D, De Biasi S, Hampel M, et al. Remodeling of T cell dynamics during long COVID is dependent on severity of SARS-CoV-2 infection.\u00a0Front Immunol. 2022;13. https:\/\/doi.org\/10.3389\/fimmu.2022.886431.","DOI":"10.3389\/fimmu.2022.886431"},{"key":"16462_CR25","doi-asserted-by":"publisher","unstructured":"Li X, Garg M, Jia T, Liao Q, Yuan L, Li M, et al. Single-cell analysis reveals the immune characteristics of myeloid cells and memory T cells in recovered COVID-19 patients with different severities. Front Immunol. 2022;12. https:\/\/doi.org\/10.3389\/fimmu.2021.781432.","DOI":"10.3389\/fimmu.2021.781432"},{"key":"16462_CR26","doi-asserted-by":"publisher","unstructured":"Kennedy AE, Cook L, Breznik JA, Cowbrough B, Wallace JG, Huynh A, et al. Lasting changes to circulating leukocytes in people with mild SARS-CoV-2 infections. Viruses. 2021;13(11). https:\/\/doi.org\/10.3390\/v13112239.","DOI":"10.3390\/v13112239"},{"issue":"3","key":"16462_CR27","first-page":"e123","volume":"29","author":"AS Hawar","year":"2022","unstructured":"Hawar AS, Dauod AS. Long COVID-19 prevalence among a sample of infected people in Erbil city. J Popul Ther Clin Pharmacol. 2022;29(3):e123\u201333.","journal-title":"J Popul Ther Clin Pharmacol"},{"issue":"1","key":"16462_CR28","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12916-021-02228-6","volume":"20","author":"FJ Ryan","year":"2022","unstructured":"Ryan FJ, Hope CM, Masavuli MG, Lynn MA, Mekonnen ZA, Yeow AEL, Garcia-Valtanen P, Al-Delfi Z, Gummow J, Ferguson C, et al. Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection. BMC Med. 2022;20(1):26.","journal-title":"BMC Med"},{"issue":"2","key":"16462_CR29","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41590-021-01113-x","volume":"23","author":"C Phetsouphanh","year":"2022","unstructured":"Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CML, Patel SK, Juno JA, Burrell LM, Kent SJ, Dore GJ, et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022;23(2):210\u20136.","journal-title":"Nat Immunol"},{"issue":"1","key":"16462_CR30","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41590-021-01095-w","volume":"23","author":"AHE Roukens","year":"2022","unstructured":"Roukens AHE, Pothast CR, K\u00f6nig M, Huisman W, Dalebout T, Tak T, Azimi S, Kruize Y, Hagedoorn RS, Zlei M, et al. Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8+ T cell responses following COVID-19. Nat Immunol. 2022;23(1):23\u201332.","journal-title":"Nat Immunol"},{"issue":"3","key":"16462_CR31","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3947\/ic.2022.0141","volume":"54","author":"Y Kim","year":"2022","unstructured":"Kim Y, Kim SE, Kim T, Yun KW, Lee SH, Lee E, Seo JW, Jung YH, Chong YP. Preliminary guidelines for the clinical evaluation and management of long COVID. Infect Chemother. 2022;54(3):566\u201397.","journal-title":"Infect Chemother"},{"issue":"8","key":"16462_CR32","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1177\/10547738221132603","volume":"31","author":"MD Pinto","year":"2022","unstructured":"Pinto MD, Chakraborty R, Lambert N. The elephant in the waiting room: an urgent call for papers to address the public health crisis of long COVID. Clin Nurs Res. 2022;31(8):1387\u20139.","journal-title":"Clin Nurs Res"},{"issue":"3","key":"16462_CR33","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/jmv.27415","volume":"94","author":"RJ O'Connor","year":"2022","unstructured":"O\u2019Connor RJ, Preston N, Parkin A, Makower S, Ross D, Gee J, Halpin SJ, Horton M, Sivan M. The COVID-19 Yorkshire rehabilitation scale (C19-YRS): application and psychometric analysis in a post-COVID-19 syndrome cohort. J Med Virol. 2022;94(3):1027\u201334.","journal-title":"J Med Virol"},{"key":"16462_CR34","doi-asserted-by":"publisher","unstructured":"Sivan M, Halpin S, Gees J, Makower S, Parkin A, Ross D, et al. The self-report version and digital format of the COVID-19 Yorkshire Rehabilitation Scale (C19-YRS) for long Covid or post-COVID syndrome assessment and monitoring.\u00a0J Clin Neurosci Rehabil. 2021;20(3). https:\/\/doi.org\/10.47795\/QROO4168.","DOI":"10.47795\/QROO4168"},{"key":"16462_CR35","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.2147\/JIR.S370788","volume":"15","author":"J Bonenfant","year":"2022","unstructured":"Bonenfant J, Li J, Nasouf L, Miller J, Lowe T, Jaroszewski L, Qiu X, Thapamagar S, Mittal A, Godzik A, et al. Resistin concentration in early sepsis and all-cause mortality at a safety-net hospital in riverside county. J Inflamm Res. 2022;15:3925\u201340.","journal-title":"J Inflamm Res"},{"key":"16462_CR36","unstructured":"Quick facts: Riverside County, CA. https:\/\/www.census.gov\/quickfacts\/riversidecountycalifornia. Accessed 14 Feb 2023."},{"issue":"8","key":"16462_CR37","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/QAD.0000000000003223","volume":"36","author":"RA Bender Ignacio","year":"2022","unstructured":"Bender Ignacio RA, Shapiro AE, Nance RM, Whitney BM, Delaney JAC, Bamford L, Wooten D, Karris MY, Mathews WC, Kim HN, et al. Racial and ethnic disparities in coronavirus disease 2019 disease incidence independent of comorbidities, among people with HIV in the United States. AIDS. 2022;36(8):1095\u2013103.","journal-title":"AIDS"},{"key":"16462_CR38","doi-asserted-by":"crossref","first-page":"94","DOI":"10.7861\/futurehosp.6-2-94","volume":"6","author":"T Davenport","year":"2019","unstructured":"Davenport T, Kalakota R. The potential for artificial intelligence in healthcare. Future Healthc J. 2019;6:94\u20138.","journal-title":"Future Healthc J"},{"key":"16462_CR39","unstructured":"Riverside University Health System \u2014 Public Health, Epidemiology & Program Evaluation. https:\/\/www.ruhealth.org\/public-health\/epidemiology-program-evaluation. Accessed 15 June 2023."},{"key":"16462_CR40","unstructured":"Patel S. Health insurance and health service utilization among children. Riverside University Health System-Public Health. 2017;9(1)."},{"key":"16462_CR41","unstructured":"Meconis, K. Health insurance coverage among adults. Riverside University Health System-Public Health. 2017;(9)2."},{"key":"16462_CR42","unstructured":"Occupational outlook handbook, labor force statistics from the current population survey. https:\/\/www.bls.gov\/cps\/cpsaat10.htm. Accessed 15 June 2023."},{"key":"16462_CR43","unstructured":"U.S. Census Bureau. https:\/\/data.census.gov\/profile\/Riverside_County,_C...?g=050XX00US06065. Accessed 15 June 2023."},{"issue":"8","key":"16462_CR44","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1001\/jama.2020.26443","volume":"325","author":"L Lopez III","year":"2021","unstructured":"Lopez L III, Hart LH III, Katz MH. Racial and ethnic health disparities related to COVID-19. JAMA. 2021;325(8):719\u201320.","journal-title":"JAMA"},{"key":"16462_CR45","doi-asserted-by":"crossref","unstructured":"Tao X, Yip T, Fisher CB. Psychological well-being and substance use during the COVID-19 pandemic: ethnic\/racial identity, discrimination, and vigilance. J Racial Ethn Health Disparities. 2022:1\u201310.","DOI":"10.1007\/s40615-022-01497-y"},{"issue":"1","key":"16462_CR46","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1134\/S1607672922060114","volume":"507","author":"MY Shkurnikov","year":"2022","unstructured":"Shkurnikov MY, Averinskaya DA, Komarov AG, Karbyshev IA, Speshilov GI, Shtinova IA, Doroshenko DA, Vechorko VI, Drapkina OM. Association of HLA class i genotype with mortality in patients with diabetes mellitus and COVID-19. Dokl Biochem Biophys. 2022;507(1):289\u201393.","journal-title":"Dokl Biochem Biophys"},{"issue":"6","key":"16462_CR47","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/s41418-022-01015-x","volume":"29","author":"Q Li","year":"2022","unstructured":"Li Q, Wang Y, Sun Q, Knopf J, Herrmann M, Lin L, Jiang J, Shao C, Li P, He X, et al. Immune response in COVID-19: what is next? Cell Death Differ. 2022;29(6):1107\u201322.","journal-title":"Cell Death Differ"},{"key":"16462_CR48","doi-asserted-by":"publisher","unstructured":"Hartley GE, Edwards ESJ, Aui PM, Varese N, Stojanovic S, McMahon J, et al. Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence.\u00a0Sci Immunol. 2020;5(54):eabf8891. https:\/\/doi.org\/10.1126\/sciimmunol.abf8891.","DOI":"10.1126\/sciimmunol.abf8891"},{"issue":"7","key":"16462_CR49","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.chom.2021.06.009","volume":"29","author":"K R\u00f6ltgen","year":"2021","unstructured":"R\u00f6ltgen K, Boyd SD. Antibody and B cell responses to SARS-CoV-2 infection and vaccination. Cell Host Microbe. 2021;29(7):1063\u201375.","journal-title":"Cell Host Microbe"},{"issue":"6","key":"16462_CR50","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1399-6576.1998.tb05306.x","volume":"42","author":"K Ohashi","year":"1998","unstructured":"Ohashi K, Yukioka H, Hayashi M, Asada A. Elevated methemoglobin in patients with sepsis. Acta Anaesthesiol Scand. 1998;42(6):713\u20136.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"8","key":"16462_CR51","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1080\/10715760802317655","volume":"42","author":"S Leoncini","year":"2008","unstructured":"Leoncini S, Rossi V, Signorini C, Tanganelli I, Comporti M, Ciccoli L. Oxidative stress, erythrocyte ageing and plasma non-protein-bound iron in diabetic patients. Free Radic Res. 2008;42(8):716\u201324.","journal-title":"Free Radic Res"},{"issue":"2","key":"16462_CR52","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1161\/ATVBAHA.109.196360","volume":"30","author":"SK Bains","year":"2010","unstructured":"Bains SK, Foresti R, Howard J, Atwal S, Green CJ, Motterlini R. Human sickle cell blood modulates endothelial heme oxygenase activity: effects on vascular adhesion and reactivity. Arterioscler Thromb Vasc Biol. 2010;30(2):305\u201312.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"16462_CR53","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1080\/14728222.2020.1762177","volume":"24","author":"T Chaikijurajai","year":"2020","unstructured":"Chaikijurajai T, Tang WHW. Myeloperoxidase: a potential therapeutic target for coronary artery disease. Expert Opin Ther Targets. 2020;24(7):695\u2013705.","journal-title":"Expert Opin Ther Targets"},{"key":"16462_CR54","doi-asserted-by":"crossref","DOI":"10.3389\/fbinf.2021.730350","volume":"1","author":"V Pimentel","year":"2021","unstructured":"Pimentel V, Mariano D, Cant\u00e3o LXS, Bastos LL, Fischer P, de Lima LHF, Fassio AV, de Melo-Minardi RC. VTR: a web tool for identifying analogous contacts on protein structures and their complexes. Front Bioinform. 2021;1: 730350.","journal-title":"Front Bioinform"},{"issue":"23","key":"16462_CR55","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1016\/j.jacc.2020.04.031","volume":"75","author":"B Bikdeli","year":"2020","unstructured":"Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, Nigoghossian C, Ageno W, Madjid M, Guo Y, et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-Up: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020;75(23):2950\u201373.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"16462_CR56","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jacc.2020.05.001","volume":"76","author":"I Paranjpe","year":"2020","unstructured":"Paranjpe I, Fuster V, Lala A, Russak AJ, Glicksberg BS, Levin MA, Charney AW, Narula J, Fayad ZA, Bagiella E, et al. Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19. J Am Coll Cardiol. 2020;76(1):122\u20134.","journal-title":"J Am Coll Cardiol"},{"issue":"7019","key":"16462_CR57","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nature03104","volume":"432","author":"TH Flo","year":"2004","unstructured":"Flo TH, Smith KD, Sato S, Rodriguez DJ, Holmes MA, Strong RK, Akira S, Aderem A. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature. 2004;432(7019):917\u201321.","journal-title":"Nature"},{"key":"16462_CR58","doi-asserted-by":"crossref","first-page":"854172","DOI":"10.3389\/fmicb.2022.854172","volume":"13","author":"Z Huang","year":"2022","unstructured":"Huang Z, Li H, Liu S, Jia J, Zheng Y, Cao B. Identification of Neutrophil-Related Factor LCN2 for Predicting Severity of Patients With Influenza A Virus and SARS-CoV-2 Infection. Front Microbiol. 2022;13:854172.","journal-title":"Front Microbiol"},{"issue":"1","key":"16462_CR59","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/JLB.4HI0720-470R","volume":"109","author":"D Zhang","year":"2021","unstructured":"Zhang D, Guo R, Lei L, Liu H, Wang Y, Qian H, Dai T, Zhang T, Lai Y, Wang J, et al. Frontline science: COVID-19 infection induces readily detectable morphologic and inflammation-related phenotypic changes in peripheral blood monocytes. J Leukoc Biol. 2021;109(1):13\u201322.","journal-title":"J Leukoc Biol"},{"issue":"6","key":"16462_CR60","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.cell.2020.08.001","volume":"182","author":"J Schulte-Schrepping","year":"2020","unstructured":"Schulte-Schrepping J, Reusch N, Paclik D, Ba\u00dfler K, Schlickeiser S, Zhang B, Kr\u00e4mer B, Krammer T, Brumhard S, Bonaguro L, et al. Severe COVID-19 Is marked by a dysregulated myeloid cell compartment. Cell. 2020;182(6):1419-1440.e1423.","journal-title":"Cell"},{"issue":"6","key":"16462_CR61","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.chom.2020.04.009","volume":"27","author":"EJ Giamarellos-Bourboulis","year":"2020","unstructured":"Giamarellos-Bourboulis EJ, Netea MG, Rovina N, Akinosoglou K, Antoniadou A, Antonakos N, Damoraki G, Gkavogianni T, Adami ME, Katsaounou P, et al. Complex immune dysregulation in covid-19 patients with severe respiratory failure. Cell Host Microbe. 2020;27(6):992-1000.e1003.","journal-title":"Cell Host Microbe"},{"key":"16462_CR62","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1002\/jmv.25948","volume":"92","author":"M Aziz","year":"2020","unstructured":"Aziz M, Fatima R, Assaly R. Elevated interleukin-6 and severe COVID-19: a meta-analysis. J Med Virol. 2020;92:2283\u20135.","journal-title":"J Med Virol"},{"key":"16462_CR63","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","volume":"46","author":"Q Ruan","year":"2020","unstructured":"Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan,\u00a0China. Intensive Care Med. 2020;46:846\u20138.","journal-title":"Intensive Care Med"},{"issue":"14","key":"16462_CR64","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1056\/NEJMra1814259","volume":"380","author":"A Rajkomar","year":"2019","unstructured":"Rajkomar A, Dean J, Kohane I. Machine learning in medicine. N Engl J Med. 2019;380(14):1347\u201358.","journal-title":"N Engl J Med"},{"issue":"2","key":"16462_CR65","first-page":"233","volume":"115","author":"MM Jacobs","year":"2023","unstructured":"Jacobs MM, Evans E, Ellis C. Racial, ethnic, and sex disparities in the incidence and cognitive symptomology of long COVID-19. J Natl Med Assoc. 2023;115(2):233\u201343.","journal-title":"J Natl Med Assoc"},{"issue":"4","key":"16462_CR66","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1002\/jmv.27456","volume":"94","author":"M Sivan","year":"2022","unstructured":"Sivan M, Parkin A, Makower S, Greenwood DC. Post-COVID syndrome symptoms, functional disability, and clinical severity phenotypes in hospitalized and nonhospitalized individuals: a cross-sectional evaluation from a community COVID rehabilitation service. J Med Virol. 2022;94(4):1419\u201327.","journal-title":"J Med Virol"},{"key":"16462_CR67","doi-asserted-by":"publisher","unstructured":"Straudi S, Manfredini F, Baroni A, Milani G, Fregna G, Schincaglia N, et al. Construct validity and responsiveness of the COVID-19 Yorkshire Rehabilitation Scale (C19-YRS) in a cohort of Italian hospitalized COVID-19 patients. Int J Environ Res Public Health. 2022;19(11). https:\/\/doi.org\/10.3390\/ijerph19116696.","DOI":"10.3390\/ijerph19116696"},{"issue":"2","key":"16462_CR68","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1089\/tmj.2022.0085","volume":"29","author":"B Ayuso Garc\u00eda","year":"2022","unstructured":"Ayuso Garc\u00eda B, Besteiro Balado Y, P\u00e9rez L\u00f3pez A, Romay Lema E, March\u00e1n-L\u00f3pez \u00c1, Rodr\u00edguez \u00c1lvarez A, Garc\u00eda Pa\u00eds MJ, Corredoira S\u00e1nchez J, Rabu\u00f1al Rey R. Assessment of post-covid symptoms using the c19-yrs tool in a cohort of patients from the first pandemic wave in northwestern Spain. Telemedicine and e-Health. 2022;29(2):278\u201383.","journal-title":"Telemedicine and e-Health"},{"issue":"2","key":"16462_CR69","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/jmv.26368","volume":"93","author":"SJ Halpin","year":"2021","unstructured":"Halpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, Walshaw C, Kemp S, Corrado J, Singh R, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J Med Virol. 2021;93(2):1013\u201322.","journal-title":"J Med Virol"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-023-16462-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-023-16462-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-023-16462-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T14:09:17Z","timestamp":1700230157000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-023-16462-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,19]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["16462"],"URL":"https:\/\/doi.org\/10.1186\/s12889-023-16462-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2800664\/v1","asserted-by":"object"}]},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,19]]},"assertion":[{"value":"11 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the institutional review boards (IRB) of Riverside University Health System Medical Center (RUHS) and the University of California Riverside (UCR) (HS-20\u2013121 and HS-20\u2013128). Study participants were informed of the risks of participation and provided written informed consent in their native language, English or Spanish. For some ICU patients who were unable to provide consent, written informed consent was waived by the IRB committee at RUHS (HS-20\u2013121), and instead, a designated surrogate decision-maker provided written consent. This study complies with the <i>Declaration of Helsinki<\/i>, except for registration in a database.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1584"}}